Alerts will be sent to your verified email
Verify EmailSHIVALIK
|
Shivalik Rasayan
|
Medico Remedies
|
Albert David
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Chemicals
|
|||
|
Capacity Utilization - Dimethoate
|
95.0 % | n/a | n/a |
|
Realization/Tonne - Dimethoate
|
299080.92 Rs/MT | n/a | n/a |
|
Realization/Tonne - Sodium hydrosulfide
|
4487.46 Rs/MT | n/a | n/a |
|
Financials
|
|||
|
5 yr Average ROE
|
6.54 % | 13.93 % | 11.47 % |
|
5yr average Equity Multiplier
|
1.82 | 2.07 | 1.63 |
|
5yr Average Asset Turnover Ratio
|
0.44 | 1.49 | 0.62 |
|
5yr Avg Net Profit Margin
|
7.94 % | 4.73 % | 11.31 % |
|
Price to Book
|
0.62 | 4.78 | 1.02 |
|
P/E
|
30.8 | 27.53 | 0.0 |
|
5yr Avg Cash Conversion Cycle
|
100.7 Days | 53.33 Days | -77.77 Days |
|
Inventory Days
|
80.64 Days | 48.95 Days | 47.91 Days |
|
Days Receivable
|
107.04 Days | 129.15 Days | 27.87 Days |
|
Days Payable
|
166.18 Days | 124.28 Days | 140.35 Days |
|
5yr Average Interest Coverage Ratio
|
8.55 | 11.55 | 93.73 |
|
5yr Avg ROCE
|
8.54 % | 20.03 % | 14.69 % |
|
5yr Avg Operating Profit Margin
|
17.6 % | 7.11 % | 9.55 % |
|
5 yr average Debt to Equity
|
0.2 | 0.26 | 0.02 |
|
5yr CAGR Net Profit
|
-1.04 % | 31.26 % | -4.92 % |
|
5yr Average Return on Assets
|
3.57 % | 6.88 % | 7.03 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
47.37 % | 61.38 % | 62.24 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-2.95 % | -11.96 % | 0.2 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Shivalik Rasayan
|
Medico Remedies
|
Albert David
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Operating Profit Break-Up
|
Operating Profit Break-Up
|
-
|
-
|
|
Asset Break-Up
|
Asset Break-Up
|
-
|
-
|